Working with TipRanks
Follow Us
Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Calendars
Economic Indicators
Calculators
Education
About Us
Working with TipRanks
Follow Us
Kevin Lofton Insider Profile
4 Followers
Kevin Lofton, Director at Gilead Sciences, holds 6.23K shares in Medtronic (Ticker: MDT), holds 92.65K shares in Gilead Sciences (Ticker: GILD), holds 46.19K shares in Rite Aid (Ticker: RADCQ).
Profitable Transactions
4 out of 6 Profitable Transactions
Average Return
+12.50%
Average return per transaction
Time Frame
Compare to
Insider Holdings
Insider Roles
Roles that Kevin Lofton holds in companies
Most Profitable Insider Trade
The most profitable trade made by Kevin Lofton
Kevin Lofton's Trading History
Gilead Sciences
May 04, 2023
Director
Uninformative Buy
―
$6.09M
Medtronic
May 03, 2024
Director
Uninformative Sell
15.53K
$512.67K
Rite Aid
Jul 09, 2021
Director
Uninformative Buy
―
$5.54K
List of latest transactions for each holding click on a transaction to see Kevin Lofton's performance on stock
You May Also Like
Kevin Lofton insider profile FAQ
What is the percentage of profitable transactions made by Kevin Lofton?
The percentage of profitable transactions made by Kevin Lofton is 67%.
What is the average return per transaction made by Kevin Lofton?
The average return per transaction made by Kevin Lofton is 12.50%.
What stocks does Kevin Lofton hold?
Kevin Lofton holds: GILD, MDT, RADCQ stocks.
What was Kevin Lofton’s latest transaction?
Kevin Lofton latest transaction was an Uninformative Sell of $15.53K.
What was Kevin Lofton's most profitable transaction?
Kevin Lofton’s most profitable transaction was an Informative Buy of GILD stock on April 29, 2022. The return on the trade was 44.40%.
What is Kevin Lofton's role in Gilead Sciences?
Kevin Lofton's role in Gilead Sciences is Director.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.